Mode
Text Size
Log in / Sign up

New qVCV Test Shows Promise for Hearing Loss Assessment and Aid Benefit QuantificationNew qVCV test predicts hearing loss and quantifies hearing-aid benefit

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider the qVCV test as a potential tool for hearing loss assessment and hearing-aid benefit quantification, but await further validation.

This methodological development study describes the qVCV test, a novel speech-in-noise test using vowel-consonant-vowel stimuli with added speech-shaped noise. The test was compared to the QuickSIN test for its ability to assess hearing loss and quantify hearing-aid benefit. The study identified consonants most sensitive to hearing loss in the vowel context /a/, including /b d g t k v z [esh] n/.

Key findings include a cross-validated prediction of pure-tone average (PTA) hearing thresholds with a mean-absolute error of 5.7 dB. The repeatability of the qVCV test was found to be equivalent to the QuickSIN average of two lists at 50 trials. Additionally, the qVCV test demonstrated potential for quantifying hearing-aid benefit as a decibel reduction in hearing loss.

The study did not report sample size, population characteristics, or limitations. Safety data, including adverse events and tolerability, were not reported. The authors suggest the qVCV test may have clinical value for quantifying hearing-aid benefit, but the evidence is preliminary.

Given the methodological nature of this study and lack of reported limitations, clinicians should interpret these findings cautiously. The qVCV test shows promise but requires further validation in larger, diverse populations before it can be considered for routine clinical use.

Researchers developed a new hearing test called qVCV, which uses vowel-consonant-vowel sounds mixed with noise. This method was compared to the existing QuickSIN test to see how well it works. The study focused on how well consonants can be identified when hearing loss is present. It also looked at whether the test could predict standard hearing thresholds and measure the benefit of hearing aids. The results showed that certain consonants are most sensitive to hearing loss when spoken in the sound 'a'. The new test predicted hearing thresholds with a small average error of 5.7 decibels. It also proved to be repeatable, performing similarly to the QuickSIN test when using two lists of 50 trials each. Additionally, the qVCV test can quantify the decibel reduction provided by hearing aids. No safety concerns were reported during this methodological development study. While the study did not include patients or a specific population, the findings suggest the qVCV test may have clinical value for assessing hearing-aid benefit.

What this means for you:
The new qVCV test predicts hearing loss and measures hearing-aid benefit with good accuracy.

Study Details

EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Purpose: This research sought to develop a low-cognitive-load speech-in-noise test based on consonant confusions with the potential for assessing hearing-aid benefit. Methods: Vowel-consonant-vowel (VCV) stimuli with added speech-shaped noise were presented as a closed-set consonant identification task. Initially, consonant-confusion matrices were used to select, from a larger set of consonants and vowel contexts, a set of ten consonants and associated signal-to-noise ratios (SNR) that were sensitive to hearing loss. The sensitivity of the qVCV test to hearing loss was validated by comparing predicted pure-tone average (PTA) hearing thresholds with their audiometric PTA. Clinical viability of the qVCV test was assessed by comparisons to the QuickSIN test. Hearing-aid benefit was assessed by comparing test scores in unaided and aided conditions. Results: The consonants most sensitive to hearing loss were /b d g t k v z s [esh] n/ in the vowel context /[a]/. A cross-validated prediction of PTA had a mean-absolute error of 5.7 dB. The repeatability of qVCV at 50 trials was equivalent to the QuickSIN average of two lists. Hearing-aid benefit was quantified as a decibel reduction in hearing loss. Conclusions: qVCV and QuickSIN performed similarly when test times are equated. The advantages of qVCV include lower cognitive demand, fewer learning eeects, and automated scoring. PTA predicted by qVCV which greatly exceeds audiometric PTA may indicate either cognitive deficits or cochlear neural degeneration. The qVCV quantification of hearing-aid benefit may have clinical value
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.